<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title>Amarin, Sarepta And Vanda: Teachable Moments In Biotech - Seeking Alpha</title>
<meta http-equiv="Content-Type" content="text/html;charset=utf-8" />
<meta http-equiv="P3P" content='CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"' />

 <script type="text/javascript">
 window.qbaka || (function(a,c){a.__qbaka_eh=a.onerror;a.__qbaka_reports=[];a.onerror=function(){a.__qbaka_reports.push(arguments);if(a.__qbaka_eh)try{a.__qbaka_eh.apply(a,arguments)}catch(b){}};a.onerror.qbaka=1;a.qbaka={report:function(){a.__qbaka_reports.push([arguments, new Error()]);},customParams:{},set:function(a,b){qbaka.customParams[a]=b},exec:function(a){try{a()}catch(b){qbaka.reportException(b)}},reportException:function(){}};var b=c.createElement("script"),e=c.getElementsByTagName("script")[0],d=function(){e.parentNode.insertBefore(b,e)};b.type="text/javascript";b.async=!0;b.src="//cdn.qbaka.net/reporting.js";"[object Opera]"==a.opera?c.addEventListener("DOMContentLoaded",d):d();qbaka.key="697c30d6de0ec176f16bc61dacb2980d"})(window,document);qbaka.options={autoStacktrace:1,trackEvents:1};
 </script>

<script type='text/javascript'>
try {
  window.external.msSiteModeCreateJumplist('SeekingAlpha - Read, Decide, Invest.');
  window.external.msSiteModeAddJumpListItem('Portfolio' ,
  'http://seekingalpha.com/account/portfolio?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
  window.external.msSiteModeAddJumpListItem('Market Currents - Real-time stock market news updates' ,
  'http://seekingalpha.com/currents/all?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
  window.external.msSiteModeAddJumpListItem('Investment Ideas' ,
  'http://seekingalpha.com/dashboard/investing_ideas?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
  window.external.msSiteModeAddJumpListItem('Income Investing, Retirement Investing and Dividend Stocks' ,
  'http://seekingalpha.com/dashboard/investing_income?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
  window.external.msSiteModeAddJumpListItem('ETFs & Portfolio Strategy' ,
  'http://seekingalpha.com/dashboard/etfs?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
  window.external.msSiteModeAddJumpListItem('Macro View, Market Economy' ,
  'http://seekingalpha.com/dashboard/macro_view?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
  window.external.msSiteModeAddJumpListItem('My Email Alerts' ,
  'http://seekingalpha.com/account/email_preferences?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
} catch (ex) {
}
</script>
<meta name="application-name" content="Seeking Alpha - Read, Decide, Invest."/>
<meta name="msapplication-TileColor" content="#360000"/>
<meta name="msapplication-TileImage" content="http://static.cdn-seekingalpha.com/images/media_kit/71cdea92-2dc1-419d-8d62-f68b74c1eda8.png"/>
<meta name="msapplication-tooltip" content="Seeking Alpha - Read, Decide, Invest." />
<meta name="msapplication-starturl" content="http://seekingalpha.com?source=ie_task" />
<meta name="msapplication-task" content="name=Portfolio ;action-uri=http://seekingalpha.com/account/portfolio?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<meta name="msapplication-task" content="name=Market Currents - Real-time stock market news updates ;action-uri=http://seekingalpha.com/currents/all?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<meta name="msapplication-task" content="name=Investment Ideas ;action-uri=http://seekingalpha.com/dashboard/investing_ideas?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<meta name="msapplication-task" content="name=Income Investing, Retirement Investing and Dividend Stocks ;action-uri=http://seekingalpha.com/dashboard/investing_income?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<meta name="msapplication-task" content="name=ETFs & Portfolio Strategy ;action-uri=http://seekingalpha.com/dashboard/etfs?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<meta name="msapplication-task" content="name=Macro View, Market Economy ;action-uri=http://seekingalpha.com/dashboard/macro_view?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<meta name="msapplication-task" content="name=My Email Alerts ;action-uri=http://seekingalpha.com/account/email_preferences?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<!-- End IE9 Settings -->

<meta property="fb:admins" content="100006791796236" />

<meta name="twitter:card" content="summary">
<meta name="twitter:site" content="@sa_popular">
<meta name="twitter:title" content="Amarin, Sarepta And Vanda: Teachable Moments In Biotech">
<meta name="twitter:description" content="The last two years or so have seen the entire biotech sector catch fire. The SPDR Biotech ETF (XBI) is up over 45% in that time, after only appreciating 26% in the six years prior.The sentiment change around biotechs appears to be linked to the record number of FDA approvals for new drugs in 2012. Specifically, the FDA approved ">
<meta name='twitter:image' content='http://static.cdn-seekingalpha.com/images/users_profile/004/638/751/big_pic.png?1381308584'><link rel="search" type="application/opensearchdescription+xml" href="/javascripts/seeking.xml" title="SeekingAlpha Search" />
<meta name="description" content="ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Amarin Corporation plc (ADR) (NASDAQ:AMRN), Sarepta Therapeutics Inc (NASDAQ:SRPT), Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), SPDR S&P Biotech (ETF) (NYSEARCA:XBI): Amarin, Sarepta And Vanda: Teachable Moments In Biotech" /><meta name="robots" content="noarchive" /><meta name="keywords" content="NASDAQ:AMRN, NASDAQ:ACAD, NASDAQ:SRPT, NASDAQ:VNDA, NYSEARCA:XBI" /><link rel="alternate" media="only screen and (max-width: 640px)" href="http://m.seekingalpha.com/article/1845212" /><meta name="original-source" content="http://seekingalpha.com/article/1845212-amarin-sarepta-and-vanda-teachable-moments-in-biotech"><meta property="og:image" content="http://static.cdn-seekingalpha.com/uploads/2013/8/19/social_sa_logo.png" />
<meta property="og:title" content="Amarin, Sarepta And Vanda: Teachable Moments In Biotech" />
<meta property="og:description" content="The last two years or so have seen the entire biotech sector catch fire. The SPDR Biotech ETF (XBI) is up over 45% in that time, after only appreciating 26% in the six years prior.The sentiment change around biotechs appears" />
<link rel="canonical" href="http://seekingalpha.com/article/1845212-amarin-sarepta-and-vanda-teachable-moments-in-biotech" />
<link href="http://static3.cdn-seekingalpha.com/stylesheets/performance_layout_packaged.css?1386241445" media="screen" rel="stylesheet" type="text/css" /><link href="http://static3.cdn-seekingalpha.com/stylesheets/performance_layout_b_packaged.css?1386241445" media="screen" rel="stylesheet" type="text/css" /><link href="http://static2.cdn-seekingalpha.com/stylesheets/article_packaged.css?1386241445" media="screen" rel="stylesheet" type="text/css" />
<script type="text/javascript">var siteon = false;</script>
<script type="text/javascript" src="/javascripts/siteon.js"></script>

<script type="text/javascript">
  var users_on_site='2,715,732';
  var user_cookie={};

  function readCookie(name) {
    var cookie = document.cookie.match(new RegExp('(^|;)\\s*' + escape(name) + '=([^;\\s]*)'));
    return (cookie ? unescape(cookie[2]) : null);
  }

  function addToCookie(key,value) {
    var arr=user_cookie[key].split(',');
    arr.push(value);

    user_cookie[key]=arr.join(',');
  }
  if (document.location.protocol == "https:") {
    document.write('<scr'+'ipt src="/account/no_cookie_key"></scri'+'pt>');
  } else if (readCookie('user_cookie_key')) {
    document.write('<scr'+'ipt src="http://static.cdn-seekingalpha.com/account/cookie/'+readCookie('user_cookie_key')+'"></scri'+'pt>');
  } else if (readCookie('user_id')) {
    document.write('<scr'+'ipt src="http://seekingalpha.com/account/no_cookie_key"></scri'+'pt>');
  }
  
    (function(){
      var url='/article/1845212-amarin-sarepta-and-vanda-teachable-moments-in-biotech';
      if (location.pathname!=url){
        if (window.history && history.replaceState) history.replaceState("", "", url+location.search);
        else location.href=url+location.search;
      }
    })();

  var isThisMyFirstPV = false;
  var _comscore = _comscore || [];
  _comscore.push({ c1: "2", c2: "8500672" });
  (function() {
    var s = document.createElement("script"), el = document.getElementsByTagName("script")[0]; s.async = true;
    s.src = (document.location.protocol == "https:" ? "https://sb" : "http://b") + ".scorecardresearch.com/beacon.js";
    el.parentNode.insertBefore(s, el);
  })();
  var _sf_startpt=(new Date()).getTime(); // chartbeat code
  var is_pro = false;
  if (document.location.protocol == "https:") {
    document.write('<link rel="shortcut icon" type="image/ico" href="https://seekingalpha-a.akamaihd.net/favicon.ico" />')
  } else {
    document.write('<link rel="shortcut icon" type="image/ico" href="http://static.cdn-seekingalpha.com/favicon.ico" />')
  }
  
    
  var ASSET_HOSTS = ["http://static.cdn-seekingalpha.com","http://static1.cdn-seekingalpha.com","http://static2.cdn-seekingalpha.com","http://static3.cdn-seekingalpha.com"];
</script>

<script type='text/javascript'>
  if (document.location.protocol !== "https:") {
    var crtg_nid="2227";
    var crtg_cookiename="cto_sa";
    var crtg_varname="crtg_content";
    function crtg_getCookie(c_name){ var i,x,y,ARRCookies=document.cookie.split(";");for(i=0;i<ARRCookies.length;i++){x=ARRCookies[i].substr(0,ARRCookies[i].indexOf("="));y=ARRCookies[i].substr(ARRCookies[i].indexOf("=")+1);x=x.replace(/^\s+|\s+$/g,"");if(x==c_name){return unescape(y);}}return'';}
    var crtg_content = crtg_getCookie(crtg_cookiename);var crtg_rnd=Math.floor(Math.random()*99999999999);
    var crtg_url=location.protocol+'//rtax.criteo.com/delivery/rta/rta.js?netId='+escape(crtg_nid);crtg_url+='&cookieName='+escape(crtg_cookiename);crtg_url+='&rnd='+crtg_rnd;crtg_url+='&varName=' + escape(crtg_varname);
    var crtg_script=document.createElement('script');crtg_script.type='text/javascript';crtg_script.src=crtg_url;crtg_script.async=true;
    if(document.getElementsByTagName("head").length>0)document.getElementsByTagName("head")[0].appendChild(crtg_script);else if(document.getElementsByTagName("body").length>0 && !SA.Utils.Env.isIE7)document.getElementsByTagName("body")[0].appendChild(crtg_script);
  }
</script>
<script src="http://static3.cdn-seekingalpha.com/javascripts/common_packaged.js?1386241403" type="text/javascript"></script>
<script src="http://static1.cdn-seekingalpha.com/javascripts/common2_packaged.js?1386241405" type="text/javascript"></script><script src="http://static.cdn-seekingalpha.com/javascripts/common_article_packaged.js?1386241407" type="text/javascript"></script><script src="//partner.googleadservices.com/gampad/google_service.js" type="text/javascript"></script>
<script>
  if (SA.Data && SA.Data.Cache) {
    var adata = SA.Data.Cache.get('campaign_content');
  }
</script>

<script type="text/javascript">
  if ((user_email_cookie=readCookie('user_email')) && user_email_cookie.indexOf('@gmail.com')!=-1) {
    createCookie('user_email',(user_email_cookie.replace('@gmail.com','').replace(/\./gi,'').replace(/\+(.*?)$/,''))+'@gmail.com',365);
  }

  if (typeof(readCookie) == "function" && readCookie('user_vocation')) {
    createCookie('u_voc',readCookie('user_vocation'),3000);
  }
  if (readCookie('sapu') == "121") {eraseCookie('sapu');}
  var user_cookie = user_cookie || {};
  eraseCookie("__article_last_size");

if (top.location.pathname == "/" && readCookie('user_id')==957061) {
  var old_SADataCookies = SA.Data.Cookies.get;
  SA.Data.Cookies.get = function(x){if (x=="user_following_users" || x=="user_watchlist_authors") return ""; else return old_SADataCookies(x);}
}
  try{(function(){
    var uc=SA.Data.Cookies.get("user_cookie_key"), t=uc ? uc.match(/t=([0-9]+)/) : null;
    if (t && t[1] < 1367771521) SA.Data.Cookies.set("user_cookie_key","");
  })();} catch(e){}
</script>

<script type="text/javascript">var NREUMQ=NREUMQ||[];NREUMQ.push(["mark","firstbyte",new Date().getTime()]);</script>      <script type="text/javascript">
  var adblock = false;
  try{
    GS_googleAddAdSenseService("ca-pub-1420150919334552");
    GS_googleEnableAllServices();
  } catch(e) {
    adblock = true;
    Mone.event("Exception","adsense1","adsense down");
  }
</script>
<script type="text/javascript">
  try{
      GA_googleAddSlot_sa('Article_120x30');
    GA_googleFetchAds();
  } catch(e) {
    adblock = true;
    Mone.event("Exception","adsense2","adsense down");
  }
</script>  </head>
    <body class="stretch_bg">
    <script>
  var ms_slug = '';
  var article_dashboards = '@sectors@';
  var article_sectors_themes = '@healthcare@article@';
  var ratings_hash={};
  var ARTICLE_ID = 1845212;
  var ARTICLE_TYPE = "standard";
  var ARTICLE_LOCK = "";
  var author_slug = "enhydrispecorp";
  var pticker_for_ads = "amrn";
  var time_left;
  var lock_comments = false;
  var machine_cookie = readCookie('machine_cookie');
  var middle_version = ABTest.identity%10;
  var sector_name = "Healthcare";
  var sector_slug = "healthcare";
  try {
    window.sessionStorage.setItem("/article/"+ARTICLE_ID, '1');
  } catch (error) {}

  
</script>
<script>var mone_article_tags = "{amrn,acad,srpt,vnda,xbi};;;{healthcare};;;{,sa-exclusive};;;{enhydrispecorp}"</script><script>var ord = Math.floor(Math.random()*1000000000);</script>
<span class="seeking_alpha_site_title">Seeking Alpha</span>
<script type="text/javascript">
  if (readCookie('sa_mobile') == '1') {
    var aHTML =[];
    aHTML.push('<div class="mobile_or_full_site">');
      aHTML.push('<span class="mobile_site" onclick="eraseCookie(\'sa_mobile\');top.location.reload()">Click here to view mobile site</span>');
      aHTML.push('<div class="cleaner"></div>');
    aHTML.push('</div>');
    document.write(aHTML.join(""));
  }
</script>
<div class="promotion_cnt finance stars ipad_top">
  <div close="close"></div>
    <a onclick='Mone.event("ipad_promotion_top","top_ipad_banner_large","ipad_promotion_top_click");' href="/download-ipad-app?source=top_ipad_banner_large" class="promotion_video">
    <div class="ptext">
      <div class="ptext_t">Seeking Alpha Portfolio App for iPad</div>
      <div class="ptext_h">Finance</div>
      <div id='ipad_stars' class="stars stars_5"></div>
      <div class="rate">(<span class="rate_num" id="rate_num">1</span>)</div>
    </div>

    <div class="free"></div>
    <div class="sep"></div>
    <div class="ipad_screenshots"></div>
  </a>
</div>
<script>
  var ipadData;
  SeekingAlpha.Initializer.AddAfterLoad(function(){
    if (SA.Utils.Env.isIPad && !/3/.test(SA.Data.Cookies.get("user_devices"))){
      Mone.event("ipad_promotion_top","top_ipad_banner_large","ipad_promotion_displayed");
      ipadData = new SA.Data.iPad();
      ipadData.instanceName = "ipadData";
      var responseHandler = new Object();
      responseHandler.handleResponse = function(data){
        if (!data.averageUserRating) return;
        var stars = data.averageUserRating < 4 ? "4" : (data.averageUserRating+"").replace(".","");
        $("ipad_stars").className = "stars stars_"+stars;
        $("rate_num").innerHTML = data.userRatingCount;
      }
      ipadData.responseDelegate = responseHandler;
      ipadData.getData();
    }
    if (SA.Utils.Env.isIPad && !/3/.test(SA.Data.Cookies.get("user_devices"))) {
      $$("body")[0].addClassName('ipad_promotion')
    }
  });
</script>
<div id="header" class="not_logged_in header_nav">
  <div id="logo_and_navigation" class="logo_and_primary_navigation">
    <div id="comment_popup" style="position:relative; left:0; display:none">
  <div id="popup_secondary">
    <div id="inner_popup"></div>
  </div>
</div>    <span class="logo_old_h1"><a href="http://seekingalpha.com/" title="Seeking Alpha - Home Page" sasource="salogo"></a></span>
    
      <div class="item banner728x90" id='top_banner_728x90'>
          <script type="text/javascript">
            iframeAd("728x90",'http://ad.doubleclick.net/adj/sek.sectors/healthcare;sz=728x90;x=x;tile=1;d=sectors;t=healthcare;aid=1845212;d=sectors;d=etfs;t=healthcare;t=article;z=3;a=enhydrispecorp;cnt=9;cnt=7;cnt=5;cnt=20;ldr=healthcare;s=amrn;s=acad;s=srpt;s=vnda;s=xbi;'+dart_my_vocation_and_profiles()+'ord='+ord+'?');
          </script>
      </div>
    
  </div>
  <div class='nav_container_wrap' id='nav_container_wrap'>
  <div id="nav_container" headtab="">
    <div id="navi_cont">
      <ul id="navi" class="navi">
        <li thistab='home' class="home">
          <a href="http://seekingalpha.com/" sasource="headtabs">Home</a>
          <span class="navi_right_corner">|</span>
        </li>
        <li thistab='portfolio' class="portfolios">
          <a href="http://seekingalpha.com/account/portfolio" sasource="headtabs">Portfolio</a>
          <span class="navi_right_corner">|</span>
        </li>
        <li thistab='market_news'>
          <a href="http://seekingalpha.com/currents/all" sasource="headtabs">Market Currents</a>
          <span class="navi_right_corner">|</span>
        </li>
        <li thistab='investing_ideas'>
          <a href="http://seekingalpha.com/dashboard/investing_ideas" sasource="headtabs">Investing Ideas</a>
          <span class="navi_right_corner">|</span>
        </li>
        <li thistab='investing_income'>
          <a href="http://seekingalpha.com/dashboard/investing_income" sasource="headtabs">Dividends &amp; Income</a>
          <span class="navi_right_corner">|</span>
        </li>
        <li thistab='etfs'>
          <a href="http://seekingalpha.com/dashboard/etfs" sasource="headtabs">ETFs</a>
          <span class="navi_right_corner">|</span>
        </li>
        <li thistab='macro_view'>
          <a href="http://seekingalpha.com/dashboard/macro_view" sasource="headtabs">Macro View</a>
          <span class="navi_right_corner">|</span>
        </li>
        <li thistab='alerts'>
          <a href="http://seekingalpha.com/real-time-alerts" sasource="headtabs">ALERTS</a>
            <span class="navi_right_corner">|</span>
          </li>
          <li thistab='pro' class="pro_tab">
            <a href="http://seekingalpha.com/account/pro" sasource="headtabs">PRO</a>
          </li>
        <li class="right_section">
          <div id="user_settings_wrapper"></div>
        </li>
      </ul>
    </div>
  </div>
    <div class="rta_nav">
      <span class="rta_nav_wrap">
        <div id="rta_nav_close" onclick="SA.Promotion.Sticky.hide()" class="close_rta">&nbsp;</div>
        <div id="related_promo_container_rel_nav" class="rta_bottom" style="display:none">
  <span class="title_wrap">
    <div class="rta_bottom_title" id="related_promo_title_nav">This article was sent to <span id="promo_num_of_rta_rel_nav">&nbsp;</span> people who get email alerts on <span class="replace_by_rel_slug">&nbsp;</span>.</div>
      <div class="title_sec">Which cover: new articles | breaking news | earnings results | dividend announcements</div>
  </span>
  <div class="rta_bottom_lnk" onclick="SA.Pages.Article.relatedPromoAction('rel_nav')">Get email alerts on <span class="replace_by_rel_slug">&nbsp;</span><span class='rta_bottom_arrow'> &raquo;</span></div>
  <div class="m_pop point_left" id="promotion_box_rel_nav" style="display:none;"></div>
</div>
<div id="related_promo_container_no_rel_nav" class="rta_bottom newsletter" style="display:none">
  <div class="rta_bottom_title">
    This article was sent to <span id="dash_newsl_subscr_count_ph_nav">&nbsp;</span> people who get the  newsletter.
    <span class="rta_bottom_lnk" onclick="SA.Pages.Article.relatedPromoAction('no_rel_nav', null)">Get the  newsletter &raquo;</span>
    <span id="promo_no_rel_loader_nav" style="display:none;"><img height="16" width="16" src="http://static3.cdn-seekingalpha.com/images/loader.gif" /></span>
  </div>
  <div class="m_pop" id="promotion_box_no_rel_nav" style="display:none;"></div>
</div>
                              </span>
    </div>
</div>
<script>
  //ABTEST: half of users go to analysis page instead of 4 dashboards
  (function(){
    if (ABTest.identity%2==0){
      var rules = [["/dashboard/investing_ideas", "/analysis/investing-ideas/all"],
                   ["/dashboard/investing_income", "/analysis/investing-income/all"],
                   ["/dashboard/etfs", "/analysis/etf-portfolio-strategy/all"],
                   ["/dashboard/macro_view", "/analysis/macro-view/all"]];
      $$('#nav_container ul li a').each(function(el){
        for (var i=0;i<rules.length;i++) el.href = el.href.replace(rules[i][0],rules[i][1]);
      });
    }
  })();
</script>
  <script type="text/javascript">
    SeekingAlpha.Initializer.LogAndRun(SA.Navigation.Top.init);
  </script>
</div>
<div id="main_container" class="white_as_before ">
  <div id="content_wrapper" class="article_pages" itemscope itemtype="http://schema.org/Article">
    <img src="http://static.cdn-seekingalpha.com/images/universal/print_logo.png" width="48" height="20" id="print_seekingalpha_logo" />
    <div class="page_top">
      <div class="search_box_container_isolated">
  <div class="search_box">
    <form id="search_box_sa_search" method="get" class="linktosym comp search" action="/search/" onsubmit="return false;">
      <fieldset>
        <input id="autocomplete_sa_search" class="input_text text" type="text" value="search by symbol, author, keyword..." size="25" autocomplete="off" onblur="if($$('.search_box'))$$('.search_box')[0].style.background='';this.style.color=this.value=='' ? '#8D8D8D' : '#000000';handleInput(this,'blur')" onfocus="if($$('.search_box'))$$('.search_box')[0].style.background='#fff';this.style.color='#000000';handleInput(this,'focus')" afteruploadvalue='eFind quotes, people, expressions, transcripts' title='search by symbol, author, keyword...' class="find_transcripts" />
        <input type="button" class="search_button" value="" onclick="if ($('autocomplete_sa_search').value!=$('autocomplete_sa_search').title) AutoCompleteSAConfig.Packages.search.Find()" />
      </fieldset>
      <input type="hidden" name="source" value="search_general" />
      <input type="hidden" id="autocomplete_sa_hidden_search" name="q" value="" />
      <input type="hidden" name="cx" value="018269914407235029540:cdhc2yeo2ko" />
      <input type="hidden" name="cof" value="FORID:11;NB:1" />
      <input type="hidden" name="goto_search_tab" value="" />
    </form>
    <script type="text/javascript">SeekingAlpha.Initializer.LogAndRun(function () { AutoCompleteSAConfig.Load('search', { Symbols:true, IframeCover:true, AfterInsert:function () { this.Find(); }, AfterSubmit:function () { this.Find(); }}) });</script>
    <script type="text/javascript" src="http://www.google.com/coop/cse/brand?form=searchbox_018269914407235029540%3Acdhc2yeo2ko&lang=en"></script>
  </div>
</div>
      <div id="article_header" class="article_content">
  <div class="top_content">
    <div id="page_header" class="page_header_email_alerts">
      <h1>
        <span itemprop="name">Amarin, Sarepta And Vanda: Teachable Moments In Biotech</span>
              </h1>
      <div id="article_info">
        
        <div class="article_info_pos">
          <span>Nov 17 2013, 10:23</span>
          <span id='title_article_comments'></span>
          <span id="page_position"></span>
          <span class="author_name_for_print">by: EnhydrisPECorp </span>
            <span  class='print_hide'>&nbsp;|&nbsp;</span>
                        <span class='print_hide'>includes: </span><span id='about_stocks'><a href="/symbol/acad" title='ACADIA Pharmaceuticals Inc.' sasource='article_about'>ACAD</a>, <a href="/symbol/amrn" title='Amarin Corporation PLC' sasource='article_about'>AMRN</a>, <a href="/symbol/srpt" title='Sarepta Therapeutics, Inc.' sasource='article_about'>SRPT</a>, <a href="/symbol/vnda" title='Vanda Pharmaceuticals Inc.' sasource='article_about'>VNDA</a>, <a href="/symbol/xbi" title='SPDR Biotech ETF' sasource='article_about'>XBI</a></span>       	</div>
        <div id="bookmark_top" class="bookmark_container">
  <div id="bookmark_title_top" class="bookmark_title">BOOKMARK<span class="added">ED</span><span class="add"> / READ LATER</span></div></span>
  <div class="bookmark_popup" id="bookmark_popup_top">
    <h2>Bookmarked</h2>
    <p>Added to your bookmarks on the Seeking Alpha homepage</p>
    <div id="btn_top" class="btn">Remove Bookmark</div>
    <div class="arr"></div>
    <div class="right_cor"></div>
  </div>
</div>
<script>
 new SA.Pages.Article.bookmark("_top");
</script>
      </div>
    </div>
  </div>
</div>
<div class="cleaner"></div>
    </div>
    <div class="cleaner"></div>
    <div id="main_content" class="no_big_gaps_main_content">
      
      <div id="article_body_container" class="no_big_gaps_article_body_container" style="float:right;">
        <div id="article_body" itemprop="articleBody">
          <div id="article_body_top2" class="disclosure_top" style="display:none;"></div>
          <p>The last two years or so have seen the entire biotech sector catch fire. The <b>SPDR Biotech ETF</b> (<a href='http://seekingalpha.com/symbol/xbi' title='SPDR Biotech ETF'>XBI</a>) is up over 45% in that time, after only appreciating 26% in the six years prior.</p><p>The sentiment change around biotechs appears to be linked to the record number of FDA approvals for new drugs in 2012. Specifically, the FDA approved <a href="http://www.forbes.com/sites/matthewherper/2012/12/05/new-drug-approval-rate-at-near-record-high-fda-says/" rel="nofollow">35</a> new biopharma products in 2012, which was more than double most previous years. The pace has definitely fallen off a bit in 2013, however, with only 20 approvals for new drugs this year so far. Nonetheless, that is still high compared to the innovation drought that occurred over the past decade.</p><p>As a result, investor enthusiasm for biotechs is at fever pitch, with a number of clinical stage biopharmas seeing their market cap soar into the billions before they've even sold a single pill or therapy. Some critics are thus calling this dramatic appreciation in the biotech sector a bubble, akin to the tech bubble that brought ruin to unsuspecting investors in the late '90s.</p><p>Per usual, I have a different view.</p><p>My take is that individual stocks within the sector are definitely &quot;bubbly-ish,&quot; but the sector as a whole is not forming a bubble per se. The main difference between the rise of biotechs and the tech crash in the '90s is that a fair number of biotechs are actually creating new, innovative products. If you recall, the tech bubble burst mainly because most of the companies weren't actually doing anything. Their stocks rose as a sector wide effect.</p><p>Biotechs, by contrast, only appreciate if the company has a compelling clinical candidate. And when the candidate fails at some point along the way, the company's stock price implodes. Simply put, there is a Darwinian &quot;survival of the fittest&quot; phenomenon going on in biotechs that keeps the sector as a whole from forming a bubble.</p><p>Individual stocks, however, are a different story altogether. Over the past two years, we have seen companies like <b>Amarin</b> (<a href='http://seekingalpha.com/symbol/amrn' title='Amarin Corporation PLC'>AMRN</a>), <b>Sarepta</b> (<a href='http://seekingalpha.com/symbol/srpt' title='Sarepta Therapeutics, Inc.'>SRPT</a>), <b>Vanda</b> (<a href='http://seekingalpha.com/symbol/vnda' title='Vanda Pharmaceuticals Inc.'>VNDA</a>), among many others, appreciate several fold based on the potential of their flagship drug candidates. When I see companies rocket up 900% before a drug is even approved (ahem, <b>Acadia Pharma</b> (<a href='http://seekingalpha.com/symbol/acad' title='ACADIA Pharmaceuticals Inc.'>ACAD</a>), I suspect that most investors new to this sector have no idea about how much risk they are taking on. In the world of biotechs, &quot;potential&quot; is interchangeable with &quot;risk,&quot; and I'll show why next.</p><p><b>Potential or risk comes in 3 forms in biotechs</b></p><p>The reason we see biotechs explode and implode with frightening regularity is because investors simply don't understand that these companies offer three ways to fail. Instead of viewing potential as risk, most investors dabbling in this sector appear to think it equates to a good chance of getting rich quick. Nothing could be further from the truth.</p><p>The first risk in the biotech game is clinical. Review <a href="http://www.nature.com/clpt/journal/v91/n3/abs/clpt2011337a.html" rel="nofollow">articles</a> have shown that new drugs fail close to 90% of the time during clinical trials, with the majority of the failures coming in Phase II studies. Basically, they frequently fail to show a clinically meaningful effect, or fail to outperform a therapy that is already approved. So if you put your money on a clinical stage biopharma, you have about a 10% chance of success. Not great odds. Yet, I've seen far too many message board posts and articles framing this stage as a drug's clinical &quot;potential,&quot; when it should be &quot;risk.&quot;</p><p>The second risk is regulatory. As we've seen from the recent Amarin, <span>Sarepta and </span>Vanda cases, the FDA is hard to predict on this front. I personally thought Amarin's Vascepa would be approved with a tight vote for its Anchor Indication and the market seemed to agree with me. Nonetheless, the panel was grumpy that day, and ended up questioning almost everything about the trial. The end result was an overwhelming no vote.</p><p>Vanda's tasimelteon got a completely different response earlier this week despite serious question marks hanging over its trial design. I think most people felt a rejection was forthcoming based on the precipitous fall in Vanda's share price leading up to the review, yet the committee ended up giving a unanimous yes vote anyways.</p><p>Finally, Sarepta's eteplirsen's hopes for accelerated approved were dashed last week, which shocked the market. The stock dropped over 60% in a single day as a result.</p><p>What's important for investors to understand is that the market grossly misjudged the regulatory risks in each of these cases. Indeed, regulatory risks are essentially a wild card in the biotech game and should be treated as such. Calling FDA decisions either way is extremely difficult to do, and investors should be aware of this fact.</p><p>Finally, the third risk is perhaps the least appreciated of the bunch - commercialization. Bringing a new drug to market takes boat loads of money. Amarin, for example, is on track to spend roughly $120 million for Vascepa's first year on the market, and that is typical for a new drug. For companies transitioning from a clinical to a commercial operation, these costs can be tough to accept. Unsuspecting investors all-too-often think their charmed biopharma that got its drug approved is finally about to turn the corner into profitability only to find out that they are facing dilution on unprecedented scales. Why? Because these companies need hundreds of millions to raise a sales force often from scratch, educate doctors, market the drug, etc. Indeed, these expenses are such a burden that many clinical stage companies simply choose to license out their lead clinical candidate, and forgo a big portion of the revenues to do so.</p><p>To top it off, many of these biotechs run up so high that they are projecting a market cap based on peak sales for the new drug. I find this hilarious because peak sales often take years to achieve, and investors are often shocked to learn that the new drug is only generating a fraction of their expectations after the first few quarters into a launch.</p><p>By misjudging each of these three risks and instead viewing them as possible rewards, the flock of new investors in the biotech sector have undoubtedly created localized bubbles. When reality sets in, however, these bubbles inevitably pop, which is healthy for the sector as a whole. This is why the sector has appreciated an average of 32% per year over the last two years, whereas some individual stocks have blasted off into the atmosphere.</p><p><b>So what's your advice on investing in this hot sector?</b></p><p>Frankly, I think picking individual stocks in this sector, for most individuals, is too difficult. Investing in biotechs requires an understanding of clinical trials, science, statistical analysis and don't forget, business. That's a tall order.</p><p>But not investing in this sector means giving up on possibly some of the best prospects for growth. So not investing is a bad idea as well.</p><p>My humble suggestion is to spread out your risk by buying a basket of biopharmas. If history serves as any guide, we can predict that roughly <a href="http://www.fda.gov/AboutFDA/WhatWeDo/History/ProductRegulation/SummaryofNDAApprovalsReceipts1938tothepresent/default.htm" rel="nofollow">63%</a> of New Drug Applications will be approved by the FDA. So selecting a handful of companies with pending NDAs could be one easy way to gain exposure to the handsome rewards of the sector, while minimizing risk.</p><p>The worst thing you can do, however, is to bet heavily on any one biotech. As I mentioned earlier, the majority of investors bet incorrectly on Amarin, <span>Sarepta and V</span>anda. Let these three cases be a cautionary tale in terms of putting your money at risk. Remember the number one rule of investing is to NOT lose money. So while I know it's fun to brag that you just made a 400% gain on some biotech, it's more likely you will be taking a loss on any individual stock in the sector. Diversification is your best friend in biopharmas and greed is your enemy.</p>
            <div id="article_source">Source: <a href="/article/1845212-amarin-sarepta-and-vanda-teachable-moments-in-biotech?source=cc">Amarin, Sarepta And Vanda: Teachable Moments In Biotech</a></div>
            <!--googleoff: index-->
            <div id="article_body_top" class="disclosure_top" style="display:none;">
              <p><strong>Disclosure: </strong>I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. <span id="additional_business_disclosure" style="display:none">I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.</span> <span onclick='uncollapse()' id='more_button' style='cursor:pointer'><strong>(More...)</strong></span></p>
              <span id="business_disclosure" style="display:none"></span>
            </div>
            <div style="clear:both"></div>
            <!--googleon: index-->
          
        </div>
        <script>SA.Pages.Article.handleDisclosures();</script>
        <div id="content_follow_up" class="underbar">
          <div id="follow_wrap">
              <div id="article_rta_bottom_container">
                <div id="related_promo_container_rel" class="rta_bottom" style="display:none">
  <span class="title_wrap">
    <div class="rta_bottom_title" id="related_promo_title">
      This article was sent to 
      <span id="promo_num_of_rta_rel">&nbsp;</span>
      people who get email alerts on 
      <span class="replace_by_rel_slug">&nbsp;</span>.
    </div>
  </span>
  <div class="rta_bottom_lnk" onclick="SA.Pages.Article.relatedPromoAction('rel');">
    Get email alerts on <span class="replace_by_rel_slug">&nbsp;</span><span class='rta_bottom_arrow'> &raquo;</span>
  </div>
  <div class="m_pop point_left" id="promotion_box_rel" style="display:none;"></div>
</div>

<div id="related_promo_container_no_rel" class="rta_bottom newsletter" style="display:none">
  <div class="rta_bottom_title">
    This article was sent to
    <span id="dash_newsl_subscr_count_ph">
      &nbsp;
    </span> people who get the  newsletter.
    <span class="rta_bottom_lnk" onclick="SA.Pages.Article.relatedPromoAction('no_rel', null)">
      Get the  newsletter &raquo;
    </span>
    <span id="promo_no_rel_loader" style="display:none;"><img height="16" width="16" src="http://static3.cdn-seekingalpha.com/images/loader.gif" /></span>
  </div>
  <div class="m_pop" id="promotion_box_no_rel" style="display:none;"></div>
</div>
<div class="fl mb10" id="roadblock_comment_unit" style="display:none">
  <div class="comments_top_area">
    <div class="comments_top_area_half">
      <div class="comments_top_area_add"><strong>Comments</strong>
      	<span id="general_comment_counter">(<span id="comments_block"></span>)</span>
      </div>
    </div>
    <div style="color:#FF6F00">
      This article has&nbsp;
      <span id="comments_block2"></span>
      &nbsp;comments. To read them or add your own, <a href="javascript:void(0)" onclick="rb=new roadblock('article crb');rb.register_show=comments_reg_show;comments_reg_show()">click here</a>.
    </div>
  </div>
</div>

<div id="techpromo_container" style="display:none" class="fl mt30 mb30 w100">
  <div id="techpromo_button" onclick="SA.Pages.Article.sendTechPromoMail()"></div>
</div>

<div id="ipadpromo_container" style="display:none" class="fl mt30 mb30 w100">
  <div id='sms_promo_line1' class='sms_line1 ml90'>The #1 Portfolio App is Now on iPad!</div>
  <div id='sms_promo_line2' class='sms_line2 ml5 fwb mt10'>Get instant notifications & never miss a critical update on your stocks!</div>
  <a href="http://seekingalpha.com/download-ipad-app?source=article_ipad_app&kind=ipad" class="fl mt30"><div id="ipadpromo_button"></div></a>
  <a href="http://seekingalpha.com/download-ipad-app?source=article_ipad_app&kind=ipad" class="fl mt20"><div id="get_the_app"></div></a>
  <div id="ipadpromo_stars" class="fl mt15"></div>
</div>

<div id="store_container" style="display:none" class="fl mt30 mb30 w100">
  <div id='sms_promo_line1' class='sms_line1 ml25'>Which Seeking Alpha App is best for you?</div>
  <div class="mt15">
    <div class="ml25">
      <div class="fl"><input id="app_portfolio" type="checkbox"/></div>
      <div class="fl fwb ml10">Seeking Alpha Portfolio</div>
      <div class="cb"></div>
    </div><div class="cb"></div>
    <div class="ml25 mt15">
      <div class="fl"><input id="app_tech" type="checkbox"/></div>
      <div class="fl fwb ml10">Tech Investor</div>
      <div class="cb"></div>
    </div><div class="cb"></div>
    <div class="ml25 mt15">
      <div class="fl"><input id="app_etf" type="checkbox"/></div>
      <div class="fl fwb ml10">ETF investor</div>
      <div class="cb"></div>
    </div><div class="cb"></div>
    <div class="ml25 mt15">
      <div class="fl"><input id="app_energy" type="checkbox"/></div>
      <div class="fl fwb ml10">Energy Investor</div>
      <div class="cb"></div>
    </div><div class="cb"></div>
    <div class="light-gray mt20 ml25">Email me a link to open from my phone:</div>
    <div class="ml25 mt5">
      <input id="email_to_download" type="text" style="width: 300px" class="fl" emailautofill="on" title="Email address" empty="Email address"/>
      <div class="bs-btn fl btn-primary ml10 btn-mini fwb" style="width: 70px;" onclick="SA.Pages.Article.sendLinkDownload()">Continue</div>
      <div class="cb"></div>
      <div class="red fs11" id="email_td_error"></div>
    </div>
  </div>
</div>

<div id="web_video_container" style="display:none" class="fl mt30 mb30">
  <iframe width="480" height="315" src="//www.youtube.com/embed/LFNN6lhLtkk" frameborder="0" allowfullscreen></iframe>
  <div class="fl mt20" style="margin-left: 194px;"><a href="http://seekingalpha.com/download-app?source=vid_bottom_article">Get the app &raquo;</a></div>
</div>

<div id="ipad_video_container" style="display:none"  class="fl mt30 mb30">
  <iframe width="480" height="315" src="//www.youtube.com/embed/zEnMPGkjOnI" frameborder="0" allowfullscreen></iframe>
  <div class="fl mt20"  style="margin-left: 194px;"><a href="http://seekingalpha.com/download-app?source=vid_bottom_article">Get the app &raquo;</a></div>
</div>


              </div>
              <div id="article_rta_middle_container" style="display:none">
                <div id="related_promo_container_rel2" class="rta_bottom" style="display:none">
  <span class="title_wrap">
    <div class="rta_bottom_title" id="related_promo_title2">
      <span id="promo_num_of_rta_rel2">
         &nbsp;
      </span>
         &nbsp;people received this article by email alert
         <span id="second_line_midelena"><br />Add your email to get alerts on <span class="replace_by_rel_slug">&nbsp;</span> too:</span>
    </div>
  </span>
  <div id="no_checkbox_midelena"><div class="rta_bottom_lnk" onclick="SA.Pages.Article.relatedPromoAction('rel2')">Get email alerts on <span class="replace_by_rel_slug">&nbsp;</span><span class='rta_bottom_arrow'> &raquo;</span></div></div>
  <div class="m_pop point_left" id="promotion_box_rel2" style="display:none;"></div>
</div>
<div id="related_promo_container_no_rel2" class="rta_bottom newsletter" style="display:none">
  <div class="rta_bottom_title">
    This article was sent to <span id="dash_newsl_subscr_count_ph2">&nbsp;</span> people who get the  newsletter.
    <span class="rta_bottom_lnk" onclick="SA.Pages.Article.relatedPromoAction('no_rel2', null)">Get the  newsletter &raquo;</span>
    <span id="promo_no_rel_loader2" style="display:none;"><img height="16" width="16" src="http://static3.cdn-seekingalpha.com/images/loader.gif" /></span>
  </div>
  <div class="m_pop" id="promotion_box_no_rel2" style="display:none;"></div>
</div>

              </div>
     		    <div id="article_tags" style="display:none">
              <div itemprop="articleSection" class="tagged_with">
                <span class="tagged_with_label">Tagged: </span><a href='/analysis/sectors/healthcare' sasource='article_navigation'>Healthcare</a>
              </div>
	          </div>
            <div class="share_this_page_article_bottom">
              <ul id="page_toolbar" class="page_toolbar">
  <li class="share_this_page_article_toolbar">
    <div class="share_this_page_snippet">
  <div id="first_line_info" style="width:490px">
    <div class="left"><h6><span id="share_slogan" class="fs16">Share this article with a colleague</span></h6></div>
  </div>
  <div class="widgets">
    <!-- Email -->

      <span class="email_this" onclick="email_story_to_friends('Article',1845212,'http://seekingalpha.com/article/1845212-amarin-sarepta-and-vanda-teachable-moments-in-biotech')">
        <div class="email_button"></div>
        <div class="email_bubble">
          <span id="widget_email_count"></span>
          <span class="cor_right"></span>
        </div>
      </span>
    <!-- twitter -->
    <span class="twitter_small">
        <a href="https://twitter.com/share" class="twitter-share-button twitter_share" data-text="Amarin, Sarepta And Vanda: Teachable Moments In Biotech http://seekingalpha.com/article/1845212-amarin-sarepta-and-vanda-teachable-moments-in-biotech?source=tweet $AMRN $ACAD $SRPT $VNDA $XBI" data-related="salphatrending" data-url=" " data-counturl="http://seekingalpha.com/article/1845212-amarin-sarepta-and-vanda-teachable-moments-in-biotech?source=share" data-count="horizontal">Tweet</a>
    </span>
    <!-- Linked In -->
      <span id="linkedin_1" class="linkedin_small linkedin_share"><script type="IN/Share" data-counter="right" data-onsuccess="linkedin_callback"></script></span>
    <!-- facebook -->
    <span id="span_fb_widget_like" class="facebook_small facebook_share"><div class="fb-like" data-href="http://seekingalpha.com/article/1845212-amarin-sarepta-and-vanda-teachable-moments-in-biotech?source=facebook" data-send="false" data-layout="button_count" data-show-faces="false" data-font="tahoma"></div></span>
    <div onclick="alert('click')">
      <div id="span_fb_widget_share" style="display: none; background: ur('/images/facebook_small.gif');" class="fb-share-button fl ml-10 mt1" data-href="http://seekingalpha.com/article/1845212-amarin-sarepta-and-vanda-teachable-moments-in-biotech?source=fb_share" data-type="button_count"></div>
    </div>
    <!-- Plusone  -->
      <span id="pluszone" class="plusone_wrap"><span class="plusone plusone_share"><div class="g-plusone" data-size="medium" annotation="bubble" data-width="65" data-callback="plusone_callback"></div></span></span>
    <!-- print -->
      <span class="print_this" onclick="print_article('with_comments')"><Print><div class="print_button"></div></span>
  </div>
</div>

  <script>
     //FB Share button test
     $('span_fb_widget_like').hide();
     $('span_fb_widget_share').show();
     setTimeout(function(){$('span_fb_widget_share').style.background="none";}, 15000);
     $('pluszone').setStyle({'margin-left':'20px'});


    SeekingAlpha.Initializer.AddAfterLoad(function(){
      new Ajax.Updater({success: 'widget_email_count'}, '/form/ajax_get_email_count', {
        method: 'get',
        parameters: {
          item_name: 'Article',
          article_id: '1845212'
        }
      });
    });

  </script>









  </script>
  </li>
</ul>            </div>
            <div class="bookmark_bottom_wrapper"><div id="bookmark_bottom" class="bookmark_container">
  <div id="bookmark_title_bottom" class="bookmark_title">BOOKMARK<span class="added">ED</span><span class="add"> / READ LATER</span></div></span>
  <div class="bookmark_popup" id="bookmark_popup_bottom">
    <h2>Bookmarked</h2>
    <p>Added to your bookmarks on the Seeking Alpha homepage</p>
    <div id="btn_bottom" class="btn">Remove Bookmark</div>
    <div class="arr"></div>
    <div class="right_cor"></div>
  </div>
</div>
<script>
 new SA.Pages.Article.bookmark("_bottom");
</script></div>
	          <div id="article_bottom_about" class="article_bottom_units"></div>
            <div id="more_by_auth" class="more_by_auth"></div>
            <div id="more_by_ticker" class="article_bottom_units"></div>
            <div id="temporary_place_holder" class="mt10"></div>
            <div class="cleaner"></div>
          </div>
            <div class="comments_with_more">
              <div id="comments_section">
              </div>
            </div>
          <div class="cleaner"></div>
          <span class="article_submit_an_article_big" onclick="submit_your_article();"></span>
        </div>
      </div>
      <div id="secondary_ads" class="no_big_gaps_secondary_ads" style="float:right;">
        <div id="author_avatar">
    <div class="follow_sidebar">
      <script>var author_info_popup_timeout;</script>
<div id="author_info"> 
  <div class="author_page_tools" id="author_image_header">
    <div class="author_info_wrap">
      <a href="/author/enhydrispecorp" class='this_is_a_author_pic' sasource="about_lpic"><img class="this_is_a_author_pic_img" align="center" src="http://static.cdn-seekingalpha.com/images/users_profile/004/638/751/big_pic.png?1381308584" width="115" height="115" alt="EnhydrisPECorp picture" onmouseover="ShowAuthorInfo();" onmouseout="HideAuthorInfo();" /></a>
 <div id="goto_edit_picture" class="goto_edit_picture" style='display:none'><span onclick="return goto_update_picture();" onmouseover="ShowAuthorInfo();" onmouseout="HideAuthorInfo();"></span></div>
        <div id="article_author_info" style="display:none;" onmouseover="clearAuthorInfoPopupTimeout();" onmouseout="HideAuthorInfo();">
          <div>
            <div class="followup_contributor_info">
  <div class="followup_contributor_info_title">
    <span>About the author: </span>
    <a href="/author/enhydrispecorp" sasource="about_name">EnhydrisPECorp</a>
  </div>

  <div class="followup_contributor_info_on_author">
    <div class="followup_contributor_info_pic_cont">
      <div class="pic_cont">
        <div class="pic_contributor">
          <div class="the_pic">
              <a href="/author/enhydrispecorp" sasource="about_pic"><img align="center" width="54" height="54" src="http://static.cdn-seekingalpha.com/images/users_profile/004/638/751/big_pic.png?1381308584" alt="EnhydrisPECorp picture"/></a>
          </div>
        </div>
      </div>
    </div>
    <div class="followup_contributor_info_text">
      Enhydris Private Equity (EPE) is a group of writers working in the fields of finance, healthcare, and technology.
    </div>
    <div class="cleaner"></div>
	</div>
  <div class="followup_contributor_info_bottom_cnt">
    
    <div class="left_cnt">
      <ul class="followup_contributor_info_content_categories"><li>Company: <a rel='nofollow' target='_blank' href='http://enhydrispecorp.com/'>Enhydris Private Equity, Inc.</a></li> <li>Blog: <a rel='nofollow' target='_blank' href='http://enhydrispe.blogspot.com/'>Enhydris Private Equity Blog</a></li></ul>
    </div>
  </div>

  <div class="cleaner"></div>
</div>
<div class="followup_contributor_info_on_author_bottom"></div>

          </div>
        </div>
    </div>
    <a href="/author/enhydrispecorp" itemprop="author" class="author_info_name" sasource="about_lname">EnhydrisPECorp</a>
    <div class="cleaner"></div>
      <span class="leaders_link">
        <div class="author_info_opinion_leader">
          <ul class="opinion_leader_list">
              <li class="lead_top_num4"><div class="content">on <a href="/analysis/sectors/healthcare" sasource="author_id">Healthcare</a></div></li>
          </ul>
        </div>
      </span>
    <div class="author_info_nav_border">
      <div class="author_info_nav">
        <ul class="the_author_info_nav">
          <li><a href='/author/enhydrispecorp/articles'>Articles <span>(82)</span></a></li>
                        <li>
                   <a href='/author/enhydrispecorp/stocktalk'>StockTalks <span>(1)</span></a>
                 </li>            <li>
                   <a href='/author/enhydrispecorp/comments'>Comments <span>(42)</span></a>
                 </li>              <script>if (/stats viewer/.test(readCookie("user_perm"))) document.write("<li><a href='/account/authorboard/earnings?for_user_id=4638751'>Earnings</a></li>");</script>
          <li><a href='/author/enhydrispecorp'>Profile</a></li>        </ul>
      </div>
    </div>
    <div class="cleaner"></div>
    <div class="user_followers_following">
      <div class="user_followers">
        <a href="/author/enhydrispecorp/followers">
          <span id="followers" class="number followers_number_4638751 followers_number_enhydrispecorp">729</span>
          <span class="text">Followers</span>
        </a>
      </div>
      <div class="user_followers">
        <a href="/author/enhydrispecorp/following">
          <span id="followings" class="number">15</span>
          <span class="text">Following</span>
        </a>
      </div>
    </div>

    <div id="follow_this_user" class="follow_this_user"></div>
    <script>Follow.author_sidebar__follow_button_initiator('enhydrispecorp')</script>
    <span class='author_info_send_message' onclick='Messaging.sendMessage("gfy4mpbzw", "Article Author ID Card Upper")'>Send Message</span>
    <div class="cleaner"></div>
  </div>
  <div class="follow_popup_wrapper">
      <div class="green_pop_wrapper" id="stop_follow" style="display:none"><div class="green_pop_top_arrow"></div><div class="green_pop"><span class="close_pop" onclick="$('stop_follow').style.display='none'"></span><p><span id="stop_follow_message"></span> EnhydrisPECorp</p><span class="stop_following" onclick="Follow.ajax_stop_follow_this_author(this, 'enhydrispecorp')">Stop Following</span></div></div><div class="green_pop_wrapper" id="no_longer_follow" style="display:none"><div class="green_pop_top_arrow"></div><div class="green_pop"><span class="close_pop" onclick="$('no_longer_follow').style.display='none'"></span><p><span id="no_longer_message"></span> EnhydrisPECorp</p></div></div>  </div>
</div>
  <script>SeekingAlpha.Initializer.onDOMLoad(function (){Follow.setFfToElements($('followers'),$('followings'),50241)})</script>

    </div>
    <div class="cleaner"></div>
    <span>About this author:</span>
<ul>
<li><a target="_blank" href="http://enhydrispecorp.com/">Visit Enhydris Private Equity, Inc.</a></li>
</ul>

    </div>
          <div class="stickyad_wrapper">
            <div class="item banner160x600" id="fixed_banner160x600">
            </div>
          </div>
      </div>
    </div>
      <script>var page_ad_src = 'http://ad.doubleclick.net/adj/sek.sectors/healthcare;sz=300x251;x=x;tile=4;d=sectors;pos=b;t=healthcare;aid=1845212;d=sectors;d=etfs;t=healthcare;t=article;z=3;a=enhydrispecorp;cnt=9;cnt=7;cnt=5;cnt=20;ldr=healthcare;s=amrn;s=acad;s=srpt;s=vnda;s=xbi;'+dart_my_vocation_and_profiles()+'ord='+ord+'?';</script>
  <div id="ads_and_tools" class="article_sidebar_tools red_sidebar">
      <div class="item banner300x600">
        <script>add_js_to_ad_call('http://ad.doubleclick.net/adj/sek.sectors/healthcare;sz=300x250,300x600;x=x;tile=2;d=sectors;pos=t;t=healthcare;aid=1845212;d=sectors;d=etfs;t=healthcare;t=article;z=3;a=enhydrispecorp;cnt=9;cnt=7;cnt=5;cnt=20;ldr=healthcare;s=amrn;s=acad;s=srpt;s=vnda;s=xbi;'+dart_my_vocation_and_profiles()+'ord='+ord+'?');</script>
      </div>
        <div id="alternative_title_container" class="mini_category data_currencies_table" style="display:none">
  <div class="sidebar_title_bk">
    <span class="sidebar_title_text" id="article_alternative_title"></span>			
  </div>
  <div id="symbol_alternative_tags" class="symbol_alternative_tags"></div>
  <div id="alternatives_pirsomet" class="alternatives_pirsomet" style="float:left;width:100%;"></div>
    <script type="text/javascript">
      ssga_always_display("Article_120x30", "http://9nl.it/i3eb/");
    </script>
  <div class="cleaner"></div>
</div>

<script type="text/javascript">
  symbol = "AMRN";
  new Ajax.Request('/articles/get_ajax_alternatives_by_symbol?symbol='+symbol, {
    asynchronous:true,
    evalScripts:true,
    method:'get',
    onComplete: function(transport) {
      if (transport.status == 200 && transport.responseText != 'failed') {
        response = transport.responseText.split("@@");
        symbolZiignight = new Ziignight('', 'SAlternative',"","symbolZiignight","symbol_alternative_tags","ETF");
        symbolZiignight.WorkJSON = eval(response[1]);
        symbolZiignight.addETF = false;
        symbolZiignight.pageType = 'Article';
        symbolZiignight.selectedSymbol = symbol;
        symbolZiignight.SAlternativePrint(-1,true);
        symbolZiignight.InsertEtfAlternativeSymbol(response[0]);
        $('article_alternative_title').innerHTML = response[0].toUpperCase() + " vs. ETF alternatives";
        $("alternative_title_container").style.display = "";
      }
    }
  });
</script>


      

        <div id="article_sidebar" class="article_sidebar">
          <div id="sidebar_down"><img src="http://static.cdn-seekingalpha.com/images/loader_recommended_articles.gif" width="64" height="64" class="loader"/></div>
        </div>

        <div class="cleaner"></div>
        <div class="stickyad_wrapper">
          <div class="item banner300x250" id="article_dart_sticky"></div>
        </div>
      <script>
          SA.Utils.Ads.add({el:$('article_dart_sticky'), HadCreated:false, size:'300x250', delta:50, info:'http://ad.doubleclick.net/adj/sek.sectors/healthcare;sz=300x251;x=x;tile=4;d=sectors;pos=b;t=healthcare;aid=1845212;d=sectors;d=etfs;t=healthcare;t=article;z=3;a=enhydrispecorp;cnt=9;cnt=7;cnt=5;cnt=20;ldr=healthcare;s=amrn;s=acad;s=srpt;s=vnda;s=xbi;'+dart_my_vocation_and_profiles()+'ord='+ord+'?'});
      </script>
  </div>
  </div>
  <input id="short_url" type="hidden" value="http://seekingalpha.com/a/13jrw" />
</div>

<div id='footer_break'><div></div></div><div id="footer">
  <div id="footernav">
    <div class="footernav_left">
      <a href="http://seekingalpha.com" class="footernav_logo"></a>
      <div class="footernav_boards">
        <div><span class="footer_title">TOP AUTHORS:</span>&nbsp;<a class="top_authors" href="http://seekingalpha.com/leader-board/opinion-leaders">The Opinion Leaders</a></div>
        <div class='top_boards'>
          <span class="footer_title">TOP USERS:</span>
          <a href="http://seekingalpha.com/leader-board/top-stocktalkers">StockTalkers</a> <span class="fl_dash">|</span>
          <a href="http://seekingalpha.com/leader-board/top-instablogs">Instablogs</a>
        </div>    
      </div>
      <div class="cleaner"></div>
    </div>
    
     <div class="footernav_share_buttons">
       <div class="fl">
         <div class="fb-like" data-href="http://www.facebook.com/pages/Seeking-Alpha/224867310939090" data-layout="button_count" data-show-faces="false" data-font="verdana" data-width="450">Follow us</div>
       </div>
      <div class="twitter_wrap ml0 fl"><a href="https://twitter.com/SAlphaTrending" class="twitter-follow-button twitter_share" data-show-count="false">Follow us</a></div>
    </div>
    <div class="footernav_right">
      <div class="footernav_links">
        <a href="http://seekingalpha.com/apps" sasource="footer">Mobile Apps</a>&nbsp;&nbsp;|&nbsp;
        <a class="small_rss" href="http://seekingalpha.com/page/feeds" sasource="footer">&nbsp;&nbsp;&nbsp;&nbsp;RSS Feeds</a>&nbsp;&nbsp;|&nbsp;
        <a href="http://seekingalpha.com/page/about_us" sasource="footer">About Us</a>&nbsp;&nbsp;|&nbsp;
        <a href="http://seekingalpha.com/page/contact" sasource="footer">Contact Us</a>
      </div>
      <div class="footernav_more_links">
        <a href="http://seekingalpha.com/page/terms-of-use" sasource="footer">Terms of Use</a> |
        <a href="http://seekingalpha.com/page/privacy" sasource="footer">Privacy</a> |
        <a href="http://www.xignite.com" rel="nofollow" target="_blank">Xignite quote data</a> |
        <span>&#169; 2013 Seeking Alpha</span>
      </div>
      <div class="cleaner"></div>
      
    </div>
   
  </div>
  <div class="cleaner"></div>
</div>  <script type="text/javascript">
    Event.observe(window, 'scroll', check_positions);

    NEW_AD_DELTA = typeof(CHANGE_AD_DELTA) != "undefined" ? CHANGE_AD_DELTA : 0;
    SA.Utils.Ads.add({el:$('fixed_banner160x600'), HadCreated:false, size:'160x600', delta:NEW_AD_DELTA, info:'http://ad.doubleclick.net/adj/sek.sectors/healthcare;sz=160x600;x=x;tile=3;d=sectors;t=healthcare;aid=1845212;d=sectors;d=etfs;t=healthcare;t=article;z=3;a=enhydrispecorp;cnt=9;cnt=7;cnt=5;cnt=20;ldr=healthcare;s=amrn;s=acad;s=srpt;s=vnda;s=xbi;'+dart_my_vocation_and_profiles()+'ord='+ord+'?'});
  </script>
<script>
  document.observe('dom:loaded', function(){
    if ($('article_source')) {$('article_source').hide();}
    if (!is_pro) {$$('.arich_promobox').each(function(o){o.show()})}
    SA.Pages.Article.primary = "";
    SA.Pages.Article.init({proSidebar: null});
    if (typeof(propromotion) != "undefined") {propromotion();}

    if (SA.Pages.Article.alpha_rich_article() || SA.Pages.Article.insiders_report_article()){
      update_pro_tracker(0,1,0,0);
    }
      
    if (location.href.match(/source=[a-z0-9_]*email[a-z0-9_]*/)) {createCookie('camefromrta',true);}
    var pagination_version = ABTest.identity%10;

    if (SA.Pages.Article.is_roadblock()){
      rb = new roadblock('article');
      rb.register_show = SA.Pages.Article.roadshow;
      Mone.event(rb.type,rb.source,"Half Article");
      SA.Pages.Article.cut_new(pagination_version);
    } else {
      if (!SA.Data.User.loggedIn() && (location.search.match(/[?&]source=(yahoo|nasdaq)/)) && !document.cookie.match(/\b(user_id|user_email|camefromrta)=/)) {
        SA.Pages.Article.hide_features_for_roadblock();
      }
    }
    if (/no_ads/i.test(window.location.href)) {SA.Pages.Article.strip_for_iframe()}

      SA.Pages.Article.btb();

  });
    SeekingAlpha.Initializer.AddAfterLoad(function(){ 
      SA.Pages.Article.articlePromo({"allSlugs":["amrn","acad","srpt","vnda","xbi"],"primarySlug":null,"dashboard_id":null,"dashboard_title":null});
    });
</script>
    <script src="http://static3.cdn-seekingalpha.com/javascripts/jspell_packaged.js?1386241418" type="text/javascript"></script>
<link href="http://static1.cdn-seekingalpha.com/stylesheets/footer_packaged.css?1386241445" media="screen" rel="stylesheet" type="text/css" /><script type="text/javascript">
  if(typeof (authors) == "undefined" || typeof (symbols) == "undefined")
    load_remote_script("http://static2.cdn-seekingalpha.com/javascripts/sa.js?1386241391");
  if(is_users_cookie_exists() && !cookieExists('tops') && typeof(tops) == "undefined")
    load_remote_script("http://static.cdn-seekingalpha.com/javascripts/tops.js?1386241100");
  Mone.renderedParams = {};
  SeekingAlpha.Initializer.AddAfterLoad(function(){SA.Performance.Utils.loadPrintStyle('http://static1.cdn-seekingalpha.com/stylesheets/print.css?t=1386241540')});

  if (SA && SA.Data && SA.Data.User && SA.Data.User.loggedIn() && SA.Data.User.email() && SA.Data.User.email().match(/@seekingalpha.com/)){
    try{$('user_settings_pop').children[0].insert("<li class='mt10'><a href='javascript:void(0)' onclick='switch_status()'>PRO ON / OFF</a></li>");}catch(e){}
  }

  function switch_status(){
    new Ajax.Request('/authentication/get_menu', {
      asynchronous:true,
      method:'get',
      onComplete: function(transport) {
        eval(transport.responseJSON.code);
      }
    });
  }

  try{
      if (!siteon){
        $('header').outerHTML += '<div id="outage_message">Most of Seeking Alpha is currently unavailable due to scheduled maintenance. Most published articles are still available for viewing. We apologize for any inconvenience.</div>';
        $('user_settings_wrapper').hide();
        $('outage_message').style.top = document.viewport.getDimensions().height -48 + "px";
      }
  } catch(e){}
</script>
<noscript>
  <img src="http://b.scorecardresearch.com/p?c1=2&c2=8500672&cv=2.0&cj=1" width="0" height="0" />
</noscript>
<script src="http://static1.cdn-seekingalpha.com/javascripts/footer_packaged.js?1386241415" type="text/javascript"></script><div id="symbol_data_script_container"></div>
<script type="text/javascript">
SeekingAlpha.Initializer.onDOMLoad(function(){
  if(SA.Pages && SA.Pages.Account && SA.Pages.Account.Portfolios){
    var a = SA.Pages.Account.Portfolios.alertsTab;
    SA.Pages.Account.Portfolios.alertsTab = function(b){if ($('ziignight_submit')) a(b);}
if (getURLParam("pu")=="all_holdings") $("tab_"+Portfolio.current_tab).click();  
}
});
if (/\/account\/portfolio/.test(location.href)) {document.getElementsByTagName("html")[0].style.overflow = "auto"};
if (!$("comment_form_wrapper") && /seekingalpha\.com\/currents\/post/.test(location.href) && $("ads_and_tools")){ $("ads_and_tools").style.position = 'absolute';$("ads_and_tools").style.top="60px";$("ads_and_tools").style.right="0";};
</script>
<style>
.portfolio_news #content_wrapper .left_content .market_currents ul#mc_news li  .bullet{* position: static;* padding:0 6px 6px 1px;}
</style>
<script>
var pubnub_test = '$|892165|17136652|12809951|52832|234601|946066|138138|119840|158117|3|6383|531163|9393711|4726401|1107427|2120371|2632411|';
try{
var auth = "|" + SA.Data.Cookies.get('user_id') + "|";
if (pubnub_test.indexOf(auth) > 0) {
var scriptElement_n = document.createElement("script");
scriptElement_n.defer = "defer";
scriptElement_n.src = 'http://static.cdn-seekingalpha.com/javascripts/utils/notify.js?144';
document.getElementsByTagName("head")[0].appendChild(scriptElement_n);
//var scriptElement = document.createElement("script");
//scriptElement.defer = "defer";
//scriptElement.src = 'http://static.cdn-seekingalpha.com/javascripts/chat.js?148';
//document.getElementsByTagName("head")[0].appendChild(scriptElement);
//var fileref=document.createElement("link")
//fileref.setAttribute("rel", "stylesheet")
//fileref.setAttribute("type", "text/css")
//fileref.setAttribute("href", "http://static.cdn-seekingalpha.com/stylesheets/chat.css?147")
//document.getElementsByTagName("head")[0].appendChild(fileref)
}
} catch(e) {
}
</script>

<script type="text/javascript">if (typeof NREUMQ !== "undefined") { if (!NREUMQ.f) { NREUMQ.f=function() {
NREUMQ.push(["load",new Date().getTime()]);
var e=document.createElement("script");
e.type="text/javascript";
e.src=(("http:"===document.location.protocol)?"http:":"https:") + "//" +
  "js-agent.newrelic.com/nr-100.js";
document.body.appendChild(e);
if(NREUMQ.a)NREUMQ.a();
};
NREUMQ.a=window.onload;window.onload=NREUMQ.f;
};
NREUMQ.push(["nrfj","beacon-5.newrelic.com","c0370b1d43","334927,334928","cldeEUAJWgldEBsASkVRUwlXFRkWUA1D",0,51,new Date().getTime(),"","","","",""]);}</script>
    <div class="cleaner"></div>
  </body>
</html>
